Dr. Lynette Sholl is an Assistant Professor of Pathology at HMS/DFCI/BWH. Her research focuses on identifying pathologic, immunohistochemical, and genetic markers that will improve the classification of lung cancer, provide predictive information regarding therapy, and provide more precise prognostic information. With the advent of high-throughput next-generation sequencing technologies, she is engaged in translation of novel observations surrounding tumors.